Back
New CentoXome

Turning Years Into Days

It takes approx. 7 years to diagnose a patient with a rare disease. With NEW CentoXome®, you can turn those years into days.

Read More

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Tests by CENTOGENE

Coronavirus Tests by CENTOGENE

At a Test Center near you, at home or customized for your business, school or event

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

CENTOGENE’S LATEST SCIENTIFIC PUBLICATIONS & WEBINARS

NEW CentoXome® – Transformando nossa experiência em sua vantagem

Os palestrantes do webinar, Dr. Charles Lourenço discutirá o poder do NEW CentoXome no…

Rewrite the Future of Rare Diseases With Multiomics

Our speakers, Maximilian Schmid M.D., Chief Commercial Officer – Diagnostics and Prof.…

Biomarker-Based Monitoring of Treatment Efficacy

The value of most metabolic biomarkers is restricted to diagnostic settings. A few…

Collaborative Discovery of Gene-Disease Associations

The delineation of novel genetic disorders is facilitated by the formation of global…

COVID-19 and Parkinson’s Disease

As one of the company’s priority diseases, CENTOGENE is continuously carrying out research…

Sharing Diagnostic Insights to Support Rare Disease Patients

Defining a disorder’s complete clinical spectrum requires a detailed description of large…

Multiomic Characterization of Rare Disease Patients

Applying a multiomic approach to rare genetic diseases has great potential to…

Improving Diagnostic Options for Rare Diseases

A diagnostic strategy for rare diseases based on a combination of standard laboratory…

Modifiers of Genetic Disease

Therapeutic strategies for monogenic diseases may be derived from the identification and…

A Novel Genetic Cause for Autoinflammation

Genetic inflammatory disorders are quite rare, particularly those presenting with a…

Company Newsletter

Keep up to date with the latest scientific insights and rare disease news
with your monthly digital edition of CentoBrief

Subscribe Now

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 28, 2021 (GLOBE NEWSWIRE) 

  • FTD is a rapidly progressing neurodegenerative disease; up to 30% of all...
Read more

Combining Expertise to Advance Precision Medicine, While Enabling a More Efficient and Timely Diagnosis of Rare Diseases Around the World

CAMBRIDGE, Mass. and...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 29, 2021 (GLOBE NEWSWIRE)

  • Collaborative research utilized insights gained from CENTOGENE’s rare...
Read more

Strong Revenues and Steady Return to Core Business Growth; Surpasses Milestone of 200 Scientific Publications, Highlighting Value of Bio/Databank

CAMBRIDGE,...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, September 1, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, July 27, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, June 25, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 24. Juni 2021

  • CENTOGENE baut sein Netzwerk an SARS-CoV-2-Testcentern in deutschen Innenstädten und an...
Read more